Derivative Financial Instruments - Warrants (Details) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Changes in the Company's derivative financial instruments liability balance
Balance of warrants outstanding at the beginning of the period (in shares)	5,533,242
Exercised (in shares)	(50,000)
Balance of warrants outstanding at the end of the period (in shares)	5,483,242
Balance of derivative financial instruments liability at the beginning of the period	$ 3,297,077
Change in fair value of warrants during the period recognized as a gain in the condensed consolidated statement of operations	(533,750)	$ 1,946,728
Balance of derivative financial instruments liability at the end of the period	$ 2,763,327
Warrants | Black Scholes Option Pricing Method
Range of assumptions used to determine the fair value of warrants
Estimated fair value of Trovagene common stock (in dollars per share)	$ 4.65	$ 6.81
Expected warrant term	2 years 9 months	3 years 9 months
Risk-free interest rate	0.87%	0.89%
Expected volatility (as a percent)	82.00%	75.00%
Dividend yield (as a percent)	0.00%	0.00%
Changes in the Company's derivative financial instruments liability balance
Balance of warrants outstanding at the beginning of the period (in shares)	967,297
Balance of warrants outstanding at the end of the period (in shares)	967,297
Balance of derivative financial instruments liability at the beginning of the period	$ 3,297,077
Balance of derivative financial instruments liability at the end of the period	$ 2,763,327